Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer

Yunfeng Wang; Yan Zhang; Zhongguo Liu; Qiuying Li; Huijing Jin

doi:10.1155/2021/3685213

Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer

Evid Based Complement Alternat Med. 2021 Nov 11:2021:3685213. doi: 10.1155/2021/3685213. eCollection 2021.

Authors

Yunfeng Wang¹, Yan Zhang², Zhongguo Liu³, Qiuying Li⁴, Huijing Jin⁵

Affiliations

¹ Department of Clinical Laboratory, Chengyang People's Hospital, Qingdao 266109, China.
² Department of Nutriology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital, Qingdao 266033, China.
³ Department of Urology Surgery, Qingdao Central Hospital, Qingdao University, Qingdao 266033, China.
⁴ Department of Imaging, Zhangqiu District People's Hospital, Jinan 250200, China.
⁵ Ward Department, Zhangqiu District People's Hospital, Jinan 250200, China.

Abstract

Background: As a traditional Chinese medicine tonic, Buzhong Yiqi decoction has the effects of invigorating Qi and lifting Yang. In this study, the effects of Buzhong Yiqi Shenge decoction combined with THP bladder perfusion on postoperative efficacy in bladder cancer were investigated.

Methods: A total of 70 cases of bladder cancer patients were divided into the experimental group and control group according to the random number table method, with 35 cases in each group. The control group was treated with THP bladder perfusion. The experimental group was treated with Buzhong Yiqi Shenge decoction on the basis of the control group. The number of urine white blood cells, VEGF level, the incidence of adverse reactions, and KPS score were compared between the two groups before and after treatment.

Results: After 3 and 6 months of therapy, the KPS score of the experimental group increased significantly compared with the control group. However, after 12 months of treatment, there was no difference in KPS scores between the two groups. Moreover, there was no significant variation in serum VEGF between two groups after 3 months of treatment. However, Buzhong Yiqi decoction notably reduced the level of VEGF after 6 months and 12 months. After 3 months, the urine white blood cell count was lower in the experimental group than in the control group. After 6 and 12 months, there was no difference in urine white blood cell count between the two groups. Furthermore, a total of 14 patients in two groups had reoccurrence after one year. Our results showed that there was no significant difference in postoperative recurrence rate between the experimental group and the control group. The occurrence rates of frequent and urgent urination, nausea/loss, and abnormal urine routine of appetite in the experimental group were significantly lower than those in the control group. But there was no difference in the occurrence rate of low heat, hematuria between the experimental group and the control group.

Conclusion: Buzhong Yiqi decoction combined with THP bladder perfusion has no advantage in the short-term recurrence rate of bladder cancer patients. However, Buzhong Yiqi decoction can alleviate the symptoms of adverse reactions and improve the quality of life of patients.